Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 147


Immunomodulation by seminal factors and implications for male-to-female HIV-1 transmission.

Keogan S, Siegert K, Wigdahl B, Krebs FC.

J Acquir Immune Defic Syndr. 2015 Jan 30. [Epub ahead of print]


Impact of viral activators and epigenetic regulators on HIV-1 LTRs containing naturally occurring single nucleotide polymorphisms.

Shah S, Pirrone V, Alexaki A, Nonnemacher MR, Wigdahl B.

Biomed Res Int. 2015;2015:320642. doi: 10.1155/2015/320642. Epub 2015 Jan 5.


Animal models of herpes simplex virus immunity and pathogenesis.

Kollias CM, Huneke RB, Wigdahl B, Jennings SR.

J Neurovirol. 2015 Feb;21(1):8-23. doi: 10.1007/s13365-014-0302-2. Epub 2014 Nov 12.


Effect of μ-opioid agonist DAMGO on surface CXCR4 and HIV-1 replication in TF-1 human bone marrow progenitor cells.

Strazza M, Banerjee A, Alexaki A, Passic SR, Meucci O, Pirrone V, Wigdahl B, Nonnemacher MR.

BMC Res Notes. 2014 Oct 23;7:752. doi: 10.1186/1756-0500-7-752.


Defining differential genetic signatures in CXCR4- and the CCR5-utilizing HIV-1 co-linear sequences.

Aiamkitsumrit B, Dampier W, Martin-Garcia J, Nonnemacher MR, Pirrone V, Ivanova T, Zhong W, Kilareski E, Aldigun H, Frantz B, Rimbey M, Wojno A, Passic S, Williams JW, Shah S, Blakey B, Parikh N, Jacobson JM, Moldover B, Wigdahl B.

PLoS One. 2014 Sep 29;9(9):e107389. doi: 10.1371/journal.pone.0107389. eCollection 2014.


Abasic phosphorothioate oligomers inhibit HIV-1 reverse transcription and block virus transmission across polarized ectocervical organ cultures.

Fraietta JA, Mueller YM, Lozenski KL, Ratner D, Boesteanu AC, Hancock AS, Lackman-Smith C, Zentner IJ, Chaiken IM, Chung S, LeGrice SF, Snyder BA, Mankowski MK, Jones NM, Hope JL, Gupta P, Anderson SH, Wigdahl B, Katsikis PD.

Antimicrob Agents Chemother. 2014 Dec;58(12):7056-71. doi: 10.1128/AAC.02991-14. Epub 2014 Sep 15.


Functional properties of the HIV-1 long terminal repeat containing single-nucleotide polymorphisms in Sp site III and CCAAT/enhancer binding protein site I.

Shah S, Alexaki A, Pirrone V, Dahiya S, Nonnemacher MR, Wigdahl B.

Virol J. 2014 May 16;11:92. doi: 10.1186/1743-422X-11-92.


Bioinformatic analysis of HIV-1 entry and pathogenesis.

Aiamkitsumrit B, Dampier W, Antell G, Rivera N, Martin-Garcia J, Pirrone V, Nonnemacher MR, Wigdahl B.

Curr HIV Res. 2014;12(2):132-61. Review.


In vivo immunogenicity of Tax(11-19) epitope in HLA-A2/DTR transgenic mice: implication for dendritic cell-based anti-HTLV-1 vaccine.

Sagar D, Masih S, Schell T, Jacobson S, Comber JD, Philip R, Wigdahl B, Jain P, Khan ZK.

Vaccine. 2014 May 30;32(26):3274-84. doi: 10.1016/j.vaccine.2014.03.087. Epub 2014 Apr 13.


Cocaine alters cytokine profiles in HIV-1-infected African American individuals in the DrexelMed HIV/AIDS genetic analysis cohort.

Parikh N, Dampier W, Feng R, Passic SR, Zhong W, Frantz B, Blakey B, Aiamkitsumrit B, Pirrone V, Nonnemacher MR, Jacobson JM, Wigdahl B.

J Acquir Immune Defic Syndr. 2014 Jul 1;66(3):256-64. doi: 10.1097/QAI.0000000000000163.


CCAAT enhancer binding protein and nuclear factor of activated T cells regulate HIV-1 LTR via a novel conserved downstream site in cells of the monocyte-macrophage lineage.

Dahiya S, Liu Y, Nonnemacher MR, Dampier W, Wigdahl B.

PLoS One. 2014 Feb 14;9(2):e88116. doi: 10.1371/journal.pone.0088116. eCollection 2014.


Epigenetics, drugs of abuse, and the retroviral promoter.

Shirazi J, Shah S, Sagar D, Nonnemacher MR, Wigdahl B, Khan ZK, Jain P.

J Neuroimmune Pharmacol. 2013 Dec;8(5):1181-96. doi: 10.1007/s11481-013-9508-y. Epub 2013 Nov 12. Review.


Immunological control of herpes simplex virus infections.

Egan KP, Wu S, Wigdahl B, Jennings SR.

J Neurovirol. 2013 Aug;19(4):328-45. doi: 10.1007/s13365-013-0189-3. Epub 2013 Aug 14. Review.


Genetic variation and HIV-associated neurologic disease.

Dahiya S, Irish BP, Nonnemacher MR, Wigdahl B.

Adv Virus Res. 2013;87:183-240. doi: 10.1016/B978-0-12-407698-3.00006-5. Review.


Extracellular HIV-1 viral protein R affects astrocytic glyceraldehyde 3-phosphate dehydrogenase activity and neuronal survival.

Ferrucci A, Nonnemacher MR, Wigdahl B.

J Neurovirol. 2013 Jun;19(3):239-53. doi: 10.1007/s13365-013-0170-1. Epub 2013 Jun 1.


Impact of age on markers of HIV-1 disease.

Pirrone V, Libon DJ, Sell C, Lerner CA, Nonnemacher MR, Wigdahl B.

Future Virol. 2013 Jan;8(1):81-101.


Global NeuroAIDS roundtable.

Joseph J, Achim CL, Boivin MJ, Brew BJ, Clifford DB, Colosi DA, Ellis RJ, Heaton RK, Gallo-Diop A, Grant I, Kanmogne GD, Kumar M, Letendre S, Marcotte TD, Nath A, Pardo CA, Paul RH, Pulliam L, Robertson K, Royal W 3rd, Sacktor N, Sithinamsuwan P, Smith DM, Valcour V, Wigdahl B, Wood C.

J Neurovirol. 2013 Feb;19(1):1-9. doi: 10.1007/s13365-012-0143-9. Epub 2013 Jan 26.


Decreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safety.

Lozenski K, Ownbey R, Wigdahl B, Kish-Catalone T, Krebs FC.

BMC Pharmacol Toxicol. 2012 Oct 1;13:9. doi: 10.1186/2050-6511-13-9.


Substance abuse, HIV-1 and hepatitis.

Parikh N, Nonnemacher MR, Pirrone V, Block T, Mehta A, Wigdahl B.

Curr HIV Res. 2012 Oct;10(7):557-71. Review.


Impact of Tat Genetic Variation on HIV-1 Disease.

Li L, Dahiya S, Kortagere S, Aiamkitsumrit B, Cunningham D, Pirrone V, Nonnemacher MR, Wigdahl B.

Adv Virol. 2012;2012:123605. doi: 10.1155/2012/123605. Epub 2012 Jul 30.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk